Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter ...

As director of the FDA's Center for Biologics Evaluation and Research, Marks has publicly supported programs that expedited ...

WASHINGTON -- Shortly before he was forced to resign, the nation’s top vaccine regulator says he refused to grant Health ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...

A federal commission is calling for $15 billion in new financing to reinforce U.S. biotech leadership amid competition from ...

FDA Chief Medical Officer Hilary Marston, M.D., is leaving her position at the agency.  | The FDA’s Chief Medical Officer ...

The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the ...

Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.

WASHINGTON (AP) — Weeks after ordering Food and Drug Administration employees back into the office, the agency is reversing ...

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second ...